Location History:
- Wielenbach, DE (1979 - 1981)
- Raisting, DE (1981 - 1984)
- Wielenbach/Obb, DE (1984)
Company Filing History:
Years Active: 1979-1984
Title: Innovator Hans-Ralf Linke: Pioneering Advances in Thyroxine and Cardiac Glycoside Research
Introduction
Hans-Ralf Linke, an accomplished inventor based in Raisting, Germany, has made significant contributions to the field of biomedical research through his innovative approaches and patented inventions. With a total of eight patents to his name, Linke's work particularly focuses on the determination of essential biochemical indices and the development of reagents for cardiac glycosides.
Latest Patents
Among Hans-Ralf Linke's latest patents is a method for the determination of the thyroxine-binding index in serum. This method involves mixing a serum sample with a defined amount of thyroxine and an enzyme covalently bound to thyroxine. By contacting the resulting solution with anti-thyroxine antibodies in a solid phase, the liquid phase can be separated, allowing the measurement of the enzyme's activity as a means to assess the thyroxine-binding index in the serum sample.
Another significant patent includes the development of new reactive asymmetrical dicarboxylic acid esters and reagents. These compounds are instrumental in preparing reagents used for the investigation of cardiac glycosides, which are vital in understanding heart function and diseases. The complexity of these compounds, indicated by various alkyl radicals and functional groups, highlights Linke's innovative spirit.
Career Highlights
Hans-Ralf Linke's contributions to the biomedical field are a testament to his expertise and dedication. Working at Boehringer Mannheim GmbH, he has been instrumental in advancing research methodologies and improving diagnostic techniques in the health sciences sector. His innovative mindset and commitment to excellence have earned him recognition within the scientific community.
Collaborations
Throughout his career, Linke has collaborated with notable colleagues such as Hans-Georg Batz and Klaus Stellner. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, which is crucial in the rapidly evolving field of biomedical research.
Conclusion
Hans-Ralf Linke has established himself as a prominent figure in the realm of biomedical innovations. His patents, particularly in the areas of thyroxine-binding index determination and reagents for cardiac glycosides, reflect his commitment to enhancing medical diagnostics and therapeutic applications. As he continues to push the boundaries of scientific research, Linke remains an influential inventor whose contributions will leave a lasting impact on the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.